Gynecology

According to a recent study in the Journal of the American Heart Association, postmenopausal women who increase their physical activity may reduce their risk of developing incident atrial fibrillation (AF).

A prospective Italian study published in The Journal of Clinical Endocrinology & Metabolism suggests that low levels of vitamin D [25(OH)D] may contribute to infertility. The finding, which the authors acknowledge does not confirm causality, could point to possible therapeutic benefits of the vitamin in women undergoing in vitro fertilization (IVF).

Despite earlier observational studies, bisphosphonate treatment for 3 to 4 years appears not to decrease the risk of invasive postmenopausal breast cancer, according to a new study in JAMA Internal Medicine.

According to a new study in Cancer Epidemiology Biomarkers & Prevention, brisk walking or vigorous exercise may help reduce risk of breast cancer in African-American women.

Avastin (bevacizumab) has been approved to treat patients with persistent, recurrent, or metastatic cervical cancer by the US Food and Drug Administration (FDA).

Eradicating morcellators is riskier than using them, says the AAGL in a statement for why these minimally invasive devices should not be abandoned.

A National Cancer Institute-funded case control study suggests that some current formulations of oral contraception (OCs) may increase risk of breast cancer.

Mutations in the PALB2 gene may be associated with a significant increase in the risk of breast cancer, according to a recent study in The New England Journal of Medicine. PALB2 binds to BRCA2-a gene that confers increased lifetime risk of developing breast or ovarian cancer-and likely permits its stable nuclear localization and accumulation.

According to a recent study in Radiology, women older than age 75 may still derive benefits from mammography screening.

Texts, emails, and voicemails may prove effective in getting surgical patients to follow preadmission instructions aimed at reducing surgical site infections.

A single-institution retrospective study published in JSLS, The Journal of the Society of Laparoendoscopic Surgeons suggests that operative times may be shorter and blood loss lower when hysterectomy is done by high-volume surgeons.

A large insurance company has decided to no longer cover laparoscopic power morcellation. Is this the beginning of the end of power morcellators?

The best-ranked hospitals for gynecology have once again been listed by U.S. News & World Report. We noticed a trend-observational only-and want to know what you think.

The ACP’s Clinical Guideline advising against pelvic examinations for the detection of pathological conditions in asymptomatic, nonpregnant, adult women is unfounded, ill timed, and ill considered.

Clinicians routinely encounter patients with bacterial vaginosis and candidiasis. Here’s how to differentiate and treat these bothersome conditions.

For surgeons who use fascial closure devices, neoClose occupies a place of its own at the head of the class.

Vulvovaginal disorders in prepubertal girls-including vulvovaginitis, lichen sclerosus, labial adhesions, urethral prolapse, and genital ulcers-are common and can be managed on an outpatient basis by a skilled clinician.

An analysis of minimally invasive hysterectomies performed at multiple institutions over a 7-year period shows that one in every 368 women who underwent morcellation had uterine cancer. According to the investigators, the study also reveals an association between advanced age and increasing prevalence of underlying cancer and endometrial hyperplasia in these patients.

The morcellation controversy heats up as physicians all over the world who use Ethicon power morcellators are being asked to return the medical devices.

A study in The New England Journal of Medicine funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development suggests that letrozole may be more effective at helping women with polycystic ovary syndrome (PCOS) become pregnant than clomiphene.

A 2-day meeting of the FDA’s Obstetrics and Gynecology Devices Advisory Committee on the safety of laparoscopic power morcellators produced recommendations, but the committee was not asked to advise as to whether the devices should be banned.

New minimally invasive robotic surgical techniques may offer some benefit to patients, but only once surgeons pass the learning curve.

Gyns morcellate fibroids because it benefits patients, not their wallet. Despite the risks, the procedure has a place in treatment, until data say otherwise.

Hormone replacement helps to maintain normal bone mineral density (BMD) in young women with primary ovarian insufficiency (POI), a study by the National Institutes of Health (NIH) has found.

Drs Louise King, Camran Nezhat, and Paul Wetter discuss an effective teamwork model, agreeing that patients have better outcomes when clinicians work as a team.